Brazil anticipates having a vaccine against COVID-19 approved and ready for use in a national inoculation program by June of next year, as reported in This is Money.
Antonio Barra Torres, the head of the country's health regulator Anvisa, said the agency has not decided on the minimum efficacy to require, but he noted it has approved vaccines in the past with less than 50% effectiveness.
Torres indicated that Anvisa could register more than one of the four candidates now being tested in Brazil, including from AstraZeneca, Sinovac Biotech, Pfizer in partnership with BioNTech, and Johnson & Johnson.
Torres said the Butantan Institute and the federal FioCruz biomedical center in Rio de Janeiro have the capacity to produce millions of doses of vaccines for Brazil and probably for other Latin American nations.
Anvisa is in talks with some Latin American countries about them accepting its registration of vaccines that will be made in Brazil, he added.
To read more NewsPoints articles, click here.